Literature DB >> 6891463

Improved medium for extraction of plasminogen activator from tissue.

S M Camiolo, M R Siuta, J M Madeja.   

Abstract

Quantitation of plasminogen activators present in tissue may depend to a large extent on the extraction procedure used to solubilize the enzymes. Potassium thiocyanate solution is known to be an efficient solubilizer, but it can inhibit assay systems other than fibrin plates. An equally effective acetate-detergent extractant is reported here which can be used with the highly sensitive azocaseinolytic assay procedure. The results indicate that a three-fold increase in activator activity can be extracted from selected tissues relative to that previously reported for a phosphate-detergent extractant. The extraction medium contains 75 mM K acetate, 0.3 M NaCl, 0.1 M L-arginine, 10 mM EDTA, 0.25% Triton X-100, final pH 4.2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6891463     DOI: 10.1080/00327488208065678

Source DB:  PubMed          Journal:  Prep Biochem        ISSN: 0032-7484


  9 in total

1.  Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness.

Authors:  C Holst-Hansen; B Johannessen; G Høyer-Hansen; J Rømer; V Ellis; N Brünner
Journal:  Clin Exp Metastasis       Date:  1996-05       Impact factor: 5.150

2.  Expression of plasminogen activator inhibitor type 1 by human prostate carcinoma cells inhibits primary tumor growth, tumor-associated angiogenesis, and metastasis to lung and liver in an athymic mouse model.

Authors:  G A Soff; J Sanderowitz; S Gately; E Verrusio; I Weiss; S Brem; H C Kwaan
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Changes in procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse.

Authors:  M A Olman; N Mackman; C L Gladson; K M Moser; D J Loskutoff
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

4.  Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue.

Authors:  C Rosenquist; S M Thorpe; K Danø; J Grøndahl-Hansen
Journal:  Breast Cancer Res Treat       Date:  1993-12       Impact factor: 4.872

5.  Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model.

Authors:  E Allaire; R Forough; M Clowes; B Starcher; A W Clowes
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

6.  Secretion of plasminogen activators by human colorectal and gastric tumor explants.

Authors:  S R Harvey; D D Lawrence; J M Madeja; S J Abbey; G Markus
Journal:  Clin Exp Metastasis       Date:  1988 Nov-Dec       Impact factor: 5.150

7.  Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies.

Authors:  E Rønne; G Høyer-Hansen; N Brünner; H Pedersen; F Rank; C K Osborne; G M Clark; K Danø; J Grøndahl-Hansen
Journal:  Breast Cancer Res Treat       Date:  1995-03       Impact factor: 4.872

8.  Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.

Authors:  P Protiva; I Sordat; P Chaubert; E Saraga; C Trân-Thang; B Sordat; A L Blum; G Dorta
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

9.  Immunocytochemical demonstration of tissue-type plasminogen activator in endocrine cells of the rat pituitary gland.

Authors:  P Kristensen; L S Nielsen; J Grøndahl-Hansen; P B Andresen; L I Larsson; K Danø
Journal:  J Cell Biol       Date:  1985-07       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.